Literature DB >> 3860273

Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.

M Lorber, M Aviram, S Linn, Y Scharf, J G Brook.   

Abstract

Plasma lipid and lipoprotein patterns were determined in 54 female patients with rheumatoid arthritis (RA). The patients were divided into four groups, on the basis of the treatment that was being administered (gold, penicillamine, hydroxychloroquine and nonsteroidal anti-inflammatory drugs). Plasma cholesterol levels were significantly reduced in all groups. The reduced plasma cholesterol level was a result of 26% and 36% reductions in low- and high-density lipoproteins (LDL and HDL), respectively. Very-low-density lipoprotein cholesterol was reduced only in the group receiving hydroxychloroquine, and this was associated with decreased plasma triglycerides in this group. Plasma apolipoprotein (apo) B, the LDL protein moiety, demonstrated a pattern similar to that shown for LDL cholesterol. Plasma apo A-I, the major HDL protein, was, however, in the normal range, suggesting an abnormal HDL fraction. Even though reduced HDL cholesterol was found in RA patients, the HDL/LDL ratio was normal and the apo A-I/apo B ratio was increased, suggesting that these patients are not at increased risk for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860273     DOI: 10.1093/rheumatology/24.3.250

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  11 in total

Review 1.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

2.  Hypocholesterolemia and risk of death in the critically ill surgical patient.

Authors:  D Gui; P L Spada; A De Gaetano; F Pacelli
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

3.  Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease.

Authors:  S M Jones; C P Harris; J Lloyd; C A Stirling; J P Reckless; N J McHugh
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

4.  Lipoprotein profile in limited systemic sclerosis.

Authors:  Eduardo F Borba; Claudia T L Borges; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

5.  Plasma lipids and lipoproteins in juvenile chronic arthritis.

Authors:  A Bakkaloglu; B Kirel; S Ozen; U Saatçi; N Beşbaş
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

6.  Altered pattern of lipids in plasma and erythrocyte membranes of rheumatoid arthritis patients.

Authors:  D Vijayakumar; K Suresh; S Manoharan
Journal:  Indian J Clin Biochem       Date:  2005-01

7.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; S Wållberg-Jonsson; G Dahlén
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

8.  Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.

Authors:  Dursun Dursunoğlu; Harun Evrengül; Bülent Polat; Halil Tanriverdi; Veli Cobankara; Asuman Kaftan; Mustafa Kiliç
Journal:  Rheumatol Int       Date:  2004-07-31       Impact factor: 2.631

9.  Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study.

Authors:  Athanasios N Georgiadis; Eleni C Papavasiliou; Evangelia S Lourida; Yannis Alamanos; Christina Kostara; Alexandros D Tselepis; Alexandros A Drosos
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

Review 10.  Atherogenic lipid profiles and its management in patients with rheumatoid arthritis.

Authors:  Michael T Nurmohamed
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.